These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18558774)

  • 1. Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice.
    Murdoch TB; Fu H; MacFarlane S; Sydora BC; Fedorak RN; Slupsky CM
    Anal Chem; 2008 Jul; 80(14):5524-31. PubMed ID: 18558774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice.
    Martin FP; Rezzi S; Philippe D; Tornier L; Messlik A; Hölzlwimmer G; Baur P; Quintanilla-Fend L; Loh G; Blaut M; Blum S; Kochhar S; Haller D
    J Proteome Res; 2009 May; 8(5):2376-87. PubMed ID: 19323467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic analysis reveals differences in urinary excretion of kiwifruit-derived metabolites in a mouse model of inflammatory bowel disease.
    Lin HM; Edmunds SJ; Zhu S; Helsby NA; Ferguson LR; Rowan DD
    Mol Nutr Food Res; 2011 Dec; 55(12):1900-4. PubMed ID: 21957058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nontargeted urinary metabolite profiling of a mouse model of Crohn's disease.
    Lin HM; Edmunds SI; Helsby NA; Ferguson LR; Rowan DD
    J Proteome Res; 2009 Apr; 8(4):2045-57. PubMed ID: 19275240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel IL-10 deficient cell transfer model for colitis.
    Ikenoue Y; Tagami T; Murata M
    Int Immunopharmacol; 2005 Jun; 5(6):993-1006. PubMed ID: 15829415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril).
    Romick-Rosendale LE; Goodpaster AM; Hanwright PJ; Patel NB; Wheeler ET; Chona DL; Kennedy MA
    Magn Reson Chem; 2009 Dec; 47 Suppl 1():S36-46. PubMed ID: 19768747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease.
    Lin HM; Barnett MP; Roy NC; Joyce NI; Zhu S; Armstrong K; Helsby NA; Ferguson LR; Rowan DD
    J Proteome Res; 2010 Apr; 9(4):1965-75. PubMed ID: 20141220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 deficiency leads to somatic mutations in a model of IBD.
    Sato Y; Takahashi S; Kinouchi Y; Shiraki M; Endo K; Matsumura Y; Kakuta Y; Tosa M; Motida A; Abe H; Imai G; Yokoyama H; Nomura E; Negoro K; Takagi S; Aihara H; Masumura K; Nohmi T; Shimosegawa T
    Carcinogenesis; 2006 May; 27(5):1068-73. PubMed ID: 16407368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic profiles are gender, disease and time specific in the interleukin-10 gene-deficient mouse model of inflammatory bowel disease.
    Tso VK; Sydora BC; Foshaug RR; Churchill TA; Doyle J; Slupsky CM; Fedorak RN
    PLoS One; 2013; 8(7):e67654. PubMed ID: 23874435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae and Staphylococcus aureus pneumonia induce distinct metabolic responses.
    Slupsky CM; Cheypesh A; Chao DV; Fu H; Rankin KN; Marrie TJ; Lacy P
    J Proteome Res; 2009 Jun; 8(6):3029-36. PubMed ID: 19368345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases.
    Nones K; Dommels YE; Martell S; Butts C; McNabb WC; Park ZA; Zhu S; Hedderley D; Barnett MP; Roy NC
    Br J Nutr; 2009 Jan; 101(2):169-81. PubMed ID: 18761777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population.
    Marrakchi R; Moussa A; Ouerhani S; Bougatef K; Bouhaha R; Messai Y; Rouissi K; Khadimallah I; Khodjet-el-Khil H; Najar T; Benammar-Elgaaeid A
    Inflamm Res; 2009 Mar; 58(3):155-60. PubMed ID: 19184348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice.
    Nishiumi S; Izumi Y; Yoshida M
    Dig Dis Sci; 2018 Jun; 63(6):1485-1496. PubMed ID: 29564669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice.
    Wohlgemuth S; Haller D; Blaut M; Loh G
    Environ Microbiol; 2009 Jun; 11(6):1562-71. PubMed ID: 19245530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Metabolic Phenotyping Reveals Differences in the Metabolic Status of Healthy and Inflammatory Bowel Disease (IBD) Children in Relation to Growth and Disease Activity.
    Martin FP; Ezri J; Cominetti O; Da Silva L; Kussmann M; Godin JP; Nydegger A
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opioid antagonist naltrexone improves murine inflammatory bowel disease.
    Matters GL; Harms JF; McGovern C; Fitzpatrick L; Parikh A; Nilo N; Smith JP
    J Immunotoxicol; 2008 Apr; 5(2):179-87. PubMed ID: 18569389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide gene expression profiling of SCID mice with T-cell-mediated Colitis.
    Brudzewsky D; Pedersen AE; Claesson MH; Gad M; Kristensen NN; Lage K; Jensen T; Tommerup N; Larsen LA; Knudsen S; Tümer Z
    Scand J Immunol; 2009 May; 69(5):437-46. PubMed ID: 19508375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.
    Ito R; Kita M; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Iwakura Y; Okanoue T; Yoshikawa T; Kataoka K; Mazda O
    Biochem Biophys Res Commun; 2008 Dec; 377(1):12-6. PubMed ID: 18796297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease.
    Xenoulis PG; Palculict B; Allenspach K; Steiner JM; Van House AM; Suchodolski JS
    FEMS Microbiol Ecol; 2008 Dec; 66(3):579-89. PubMed ID: 18647355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse.
    Yap IK; Li JV; Saric J; Martin FP; Davies H; Wang Y; Wilson ID; Nicholson JK; Utzinger J; Marchesi JR; Holmes E
    J Proteome Res; 2008 Sep; 7(9):3718-28. PubMed ID: 18698804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.